Lv1
40 积分 2022-12-05 加入
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
4天前
已完结
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
5天前
已完结
[Progress on clinical trials of common gastrointestinal cancer drugs in China from 2012 to 2021]
2年前
已完结
Limited-stage Diffuse Large B-cell Lymphoma
2年前
已完结
皖公网安备34019202002308
